These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 495799)

  • 1. The relation of time spent in drug abuse treatment to posttreatment outcome.
    Simpson DD
    Am J Psychiatry; 1979 Nov; 136(11):1449-53. PubMed ID: 495799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Client evaluations of drug abuse treatment in relation to follow-up outcomes.
    Simpson DD; Lloyd MR
    Am J Drug Alcohol Abuse; 1979; 6(4):397-411. PubMed ID: 549469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug abuse treatment readmissions and outcomes. Three-year follow-up of DARP patients.
    Simpson DD; Savage LJ
    Arch Gen Psychiatry; 1980 Aug; 37(8):896-901. PubMed ID: 7406653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agency differences in posttreatment outcomes: a follow-up of drug abuse treatment clients.
    Joe GW; Singh BK; Lehman W; Simpson DD; Sells SB
    Int J Addict; 1983 May; 18(4):523-38. PubMed ID: 6629561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for drug abuse. Follow-up outcomes and length of time spent.
    Simpson DD
    Arch Gen Psychiatry; 1981 Aug; 38(8):875-80. PubMed ID: 7259424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of opioid addicts 5 years after admission to drug abuse treatment.
    Bracy SA; Simpson DD
    Am J Drug Alcohol Abuse; 1982-1983; 9(2):115-27. PubMed ID: 7171076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Client types in different drug abuse treatments: comparisons of follow-up outcomes.
    Simpson DD; Savage LJ
    Am J Drug Alcohol Abuse; 1981-1982; 8(4):401-18. PubMed ID: 7348105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up evaluation of treatment of drug abuse during 1969 to 1972.
    Simpson DD; Savage LJ; Lloyd MR
    Arch Gen Psychiatry; 1979 Jul; 36(7):772-80. PubMed ID: 454093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment re-entry and outcomes of opioid addicts during a four-year follow-up after drug abuse treatment in the United States.
    Simpson DD; Savage LJ
    Bull Narc; 1980; 32(4):1-10. PubMed ID: 6912076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the effectiveness of treatment for drug abuse: evidence from the DARP research programme in the United States.
    Sells SB; Simpson DD
    Bull Narc; 1979; 31(1):1-11. PubMed ID: 260891
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug abuse treatment process: a review of the literature.
    Allison M; Hubbard RL
    Int J Addict; 1985 Sep; 20(9):1321-45. PubMed ID: 3000959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between time spent in treatment and client outcomes from therapeutic communities.
    Condelli WS; Hubbard RL
    J Subst Abuse Treat; 1994; 11(1):25-33. PubMed ID: 8201630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug abuse treatment retention and process effects on follow-up outcomes.
    Simpson DD; Joe GW; Rowan-Szal GA
    Drug Alcohol Depend; 1997 Sep; 47(3):227-35. PubMed ID: 9306048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of time in drug abuse treatment and employment on posttreatment drug use and criminal activity.
    French MT; Zarkin GA; Hubbard RL; Rachal JV
    Am J Drug Alcohol Abuse; 1993; 19(1):19-33. PubMed ID: 8382448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature and status of drug abuse treatment.
    Nurco DN; Kinlock TW; Hanlon TE
    Md Med J; 1994 Jan; 43(1):51-7. PubMed ID: 8183085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped?
    Kosten TR; Rounsaville BJ; Kleber HD
    Arch Gen Psychiatry; 1987 Mar; 44(3):281-4. PubMed ID: 3827521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women in drug abuse treatment programs: factors that influence retention at very early and later stages in two treatment modalities. A summary.
    Moise R; Reed BG; Conell C
    Int J Addict; 1981 Oct; 16(7):1295-300. PubMed ID: 7327794
    [No Abstract]   [Full Text] [Related]  

  • 20. Fixed and dynamic predictors of client retention in therapeutic communities.
    Condelli WS; De Leon G
    J Subst Abuse Treat; 1993; 10(1):11-6. PubMed ID: 8383775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.